Contract Services Investment Update

A review of the latest investments in facilities, equipment, and acquisitions by biopharma contract service providers.

Biopharmaceutical contract service providers have advanced their capabilities and offerings to help their clients tackle industry challenges and accelerate innovations. The author explores some of the latest investments in facilities and equipment by contract service providers, as well as the mergers and acquisitions market.

Read this article in BioPharm International's Outsourcing Resources 2018 eBook.

View other articles in BioPharm International's Outsourcing Resources 2018 eBook.

Article Details

BioPharm International
eBook: Outsourcing Resources 2018
March 2018
Pages: 33–35

Citation

When referring to this article, please cite it as A. Lowry, “Contract Services Investment Update," BioPharm International Outsourcing Resources 2018 (March 2018).

Articles in this issue

over 7 years ago

Article

Quality Oversight During Sterile Filling Operations

over 7 years ago

Article

Good Quality Agreements Support Compliance with CGMP

over 7 years ago

Article

Gaining Analytical Insight in the Development of Biologics

over 7 years ago

Article

Process Validation in Biologics Development

over 7 years ago

Article

Bigger is Better in Samsung's Approach to Biomanufacturing

over 7 years ago

Article

Choosing an Analytical Partner in Early Drug Development

over 7 years ago

Article

Outsourcing: Does Focus Pay Off?

over 7 years ago

Article

Avoiding Complete Response Letters

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!